Sears, Angie’s List Spike — Thursday’s IP Market Recap

by Kyle Woodley | February 23, 2012 4:47 pm

InvestorPlace Market Recap[1]Sears Holdings (NASDAQ:SHLD[2]) was the talk of trading Thursday after its plans to bolster its balance sheet buffered the blow from a lousy fourth-quarter earnings report.

The company announced it would sell a handful of stores, reduce inventories and spin off its Sears Hometown and Outlet chains, which should generate about $1 billion all told. With the thought of bankruptcy mostly killed off, investors ran up SHLD stock about 19%.

That jump came despite a fourth-quarter loss of $2.4 billion, or $22.63 per share, just a year after making $3.43 in profits. Adjusted earnings of 54 cents per share also fell well short of expectations of 78 cents, and lower revenues of $12.5 billion barely beat estimates.

2011 IPO offering Angie’s List (NASDAQ:ANGI[3]) gained about 7% despite a nearly $6 million loss in its first quarterly report as a publicly traded company[4]. Investors were buoyed by strong gains in revenues (up 70%) and membership base (78%), as well as current-quarter revenue forecasts above Street expectations.

Overshadowing both Sears’ and Angie’s List’s gains was Vivus (NASDAQ:VVUS[5]), which jumped 77% to an all-time high of $18.73 on positive news concerning its appetite-suppressing drug, Qnexa[6]

. A Food & Drug Administration advisory committee recommended approval for the drug, and while not a mandate, it’s likely to go through. The company also is examining Qnexa for potential use to treat diabetes and sleep apnea.

Three Up

Three Down

Kyle Woodley[13] is the assistant editor of InvestorPlace.com[14]. As of this writing, he did not hold a position in any of the aforementioned securities. Check out recaps from previous trading days here[15].

Endnotes:
  1. [Image]: https://investorplace.com/hot-topics/investorplace-market-recap/
  2. SHLD: http://studio-5.financialcontent.com/investplace/quote?Symbol=SHLD
  3. ANGI: http://studio-5.financialcontent.com/investplace/quote?Symbol=ANGI
  4. first quarterly report as a publicly traded company: https://investorplace.com/ipo-playbook/angies-list-earnings-thrill-investors/
  5. VVUS: http://studio-5.financialcontent.com/investplace/quote?Symbol=VVUS
  6. on positive news concerning its appetite-suppressing drug, Qnexa: https://investorplace.com/2012/02/vivus-soars-on-an-anti-obesity-drugs-likely-approval/
  7. OREX: http://studio-5.financialcontent.com/investplace/quote?Symbol=OREX
  8. PCS: http://studio-5.financialcontent.com/investplace/quote?Symbol=PCS
  9. S: http://studio-5.financialcontent.com/investplace/quote?Symbol=S
  10. GTI: http://studio-5.financialcontent.com/investplace/quote?Symbol=GTI
  11. GNK: http://studio-5.financialcontent.com/investplace/quote?Symbol=GNK
  12. SWY: http://studio-5.financialcontent.com/investplace/quote?Symbol=SWY
  13. Kyle Woodley: https://investorplace.com/author/kyle-woodley/
  14. InvestorPlace.com: https://investorplace.com/
  15. here: https://investorplace.com/hot-topics/investorplace-market-recap/

Source URL: https://investorplace.com/2012/02/sears-angies-list-spike-shld-angi-vvus/